InsiderCluster

MDLN

NasdaqGS

Medline Inc.

$34.51
▼ -2.16 (-5.88%)

Price

-3.22% over 1D

Key statistics

Previous close$36.67
Day range34.47 – 36.50
52-week range32.82 – 50.88
Volume14.4M
CurrencyUSD
ExchangeNasdaqGS
Crowd sentiment
80Bullish

Insider activity

SEC EDGAR ↗
Open-mkt buys
0
$0.00
Open-mkt sells
2
$3,677,115.30
Net flow
−3.68M
2 open-market trades

Showing 17 recent filings. 15 other (grants, option exercises, gifts, tax withholding) are listed below but excluded from buy/sell flow.

InsiderTypeSharesPriceValueDate
Abrams William J
See Remarks
Tax withholding1.31K$36.61$47,885.882026-06-15
Shryock Christopher P
Chief Human Resources Officer
Tax withholding872$36.61$31,923.922026-06-15
Miller Stephen L
Chief Operating Officer
Tax withholding1.89K$36.61$69,156.292026-06-15
Liberman Alexander M.
Chief Legal Officer
Tax withholding872$36.61$31,923.922026-06-15
Laabs Amanda H.
Chief Product Officer
Tax withholding1.89K$36.61$69,156.292026-06-15
Drazin Michael B
Chief Financial Officer
Tax withholding1.89K$36.61$69,156.292026-06-15
Golwas Douglas P
Chief Commercial Officer, 10% Owner
Tax withholding1.89K$36.61$69,156.292026-06-15
Golwas Douglas P
Chief Commercial Officer, 10% Owner
Option exercise100K——2026-06-16
Golwas Douglas P
Chief Commercial Officer, 10% Owner
Sell (open market)61.97K$36.60$2,267,955.602026-06-16
Golwas Douglas P
Chief Commercial Officer, 10% Owner
Sell (open market)38.03K$37.05$1,409,159.702026-06-16
Golwas Douglas P
Chief Commercial Officer, 10% Owner
Disposition100K——2026-06-16
Golwas Douglas P
Chief Commercial Officer, 10% Owner
Option exercise100K$0.00—2026-06-16
Boyle James M
Director, Chief Executive Officer
Tax withholding2.37K$36.61$86,765.702026-06-15
GALANTI RICHARD A
Director
Grant / award11.01K——2025-12-16
GALANTI RICHARD A
Director
Grant / award5.39K$0.00—2026-06-11
Sweet Thomas W
Director
Grant / award12.41K——2025-12-16
Sweet Thomas W
Director
Grant / award5.39K$0.00—2026-06-11

Source: SEC EDGAR Forms 4/4A (CIK 2046386). Click an insider to open the original filing.

Social sentiment

80
Bullish

Volume-weighted across live social sources

StockTwitsLIVE
8 bull802 bear
Recent posts
@PencilNeckGeek· StockTwits7h ago

$MDLN Watching for entry 👀. Will be surprised if it doesn't bounce

@theWashedGod· StockTwits7h ago

$MDLN roughly 275 shares in.. i bought the dip the last 2 days. This is my favorite stock right now & I am holding semi long term

@NYC17· StockTwits22h ago

$MDLN Look at that inflow volume 🧐

@ZZZZniiiiight· StockTwits1d ago

$MDLN I’m at 34.85 1200 shares

@ISmokeCigs· StockTwits1d ago

$MDLN grabbing some here

@EarningsInsider· StockTwits1d ago

https://www.marketbeat.com/earnings/reports/2026-8-5-medline-stock/ $MDLN Medline Earnings Transcript

@murahrah· StockTwits1d ago

$MDLN People dont get this stock; sales growth is what matters; more sales more they convert over to their branded products eventually; they play the long game; CAH and MCK have no chance over the LT

@HannibalTunis· StockTwits1d ago

$MDLN loading here 30%

@OpenOutcrier· StockTwits1d ago

$MDLN (-15.4% pre) Earnings Flash (MDLN) Medline Inc. Posts Q2 Adjusted EPS $0.50 per Share, vs. FactSet Est of $0.32 https://ooc.bz/l/110027

@flabb· StockTwits1d ago

$MDLN looks really interesting under 38.00 the redder the better to accumulate

@ZZZZniiiiight· StockTwits1d ago

$MDLN well this is dead for a few quarters! Won’t be touching 50-60 this year but maybe next fall!!

@StocktwitsEarnings· StockTwits1d ago

$MDLN Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.07 • Reported revenue of $7.68B up 11.60% YoY • Medline is updating its full year 2026 outlook for Organic Sales growth to 9.0% to 10.0% and expects Adjusted EBITDA to be between $3.3 billion and $3.4 billion for 2026.

Latest news

RBC Capital Adjusts Medline Price Target to $46 From $53, Maintains Outperform Rating

MT Newswires·9h agoBullish

BofA Securities Adjusts Price Target on Medline to $46 From $53

MT Newswires·10h agoNeutral

Deutsche Bank Adjusts Medline Price Target to $37 From $42, Maintains Hold Rating

MT Newswires·10h agoNeutral

Truist Securities Adjusts Price Target on Medline to $47 From $56, Maintains Buy Rating

MT Newswires·13h agoNeutral

Analyst Report: Medline Inc.

Morningstar Research·1d agoNeutral

Medline Inc (MDLN) (Q2 2026) Earnings Call Highlights: Strong Growth Amidst Strategic ...

GuruFocus.com·1d agoBullish

These Two Medical Stocks Are Screaming Sell — Here's What Happened

Investor's Business Daily·1d agoBearish

Medline Q2 Earnings Call Highlights

MarketBeat·1d agoNeutral

Here's What Key Metrics Tell Us About Medline (MDLN) Q2 Earnings

Zacks·1d agoNeutral

Medline falls sharply as Tracy facility fire drives 58% net income drop

Investing.com·1d agoBearish

Get insider-buy alerts

Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.